B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged

B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged — Trials · CancerIndex

Clinical trials

Registered studies

1 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03579888	CD19-Specific T Cells Post AlloSCT	terminated	Phase 1	4	M.D. Anderson Cancer CenterOTHER	1	Jun 2, 2021	clinicaltrials

Data updated 22 days agoSource updated Jun 2, 2021source: clinicaltrials